Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 December 2022 | Story Gerda-Marié van Rooyen | Photo Supplied
Olebogeng TIhong
Olebogeng TIhong loves stages and cameras. She is currently studying law.

An ex-CyberSta presenter has recently made her soap debut in The River.

Olebogeng Tlhong, a fourth-year LLB student at the UFS, recently portrayed the part of a celebrity, something she says works perfectly with her personality. However, acting is only one of her many gifts and interests.

She also owns an enterprise. “I established my online store in 2020 during the COVID-19 pandemic and registered my company in October 2021.” This company, a segment of Greys World, consists of an events company, bikini line, cosmetics and accessory stores and a clothing aspect.

Passionate about the entertainment space

This born Johannesburger describes herself as a “vibrant, hard-working, resilient and multifaceted woman who loves life and all that it has to offer”. Confidence is something she has in ample supply. “I have always been a confident individual. I have participated in public-speaking competitions from a young age. I am passionate about the entertainment space.” She loves people too. "I draw inspiration from different people for different reasons and aspects of my life. This includes from the women in my family to service workers’ stories, celebrity figures and the teachings of Christ.” 

Visualisation is something this entertainer strongly believes in. “The kind of life that I envision for myself, inspires me. I want to own my time and live on my terms. Having a vision board and holding myself accountable has played a large role in ensuring that I execute everything that I said I would. I believe in being proactive and solution based.” 

Crossing boundaries and achieving dreams

Olebogeng dreams of leaving a legacy echoing her courage to cross boundaries and achieve her dreams. “I want people to draw inspiration from me and know that they can achieve anything – regardless of obstacles or one’s past. One can build an empire from nothing,” says this wanna-be world traveller.

While it is uncertain where Olebogeng’s river will take her, one thing is certain, she’ll always seize the day. “I want to remain teachable to grow. The aim is to never get comfortable and to keep striving for more.”

 


 

Olebogeng appeared on The River, episode 240, that aired beginning/mid-October.

 


 

This guest appearing actress has always been confident. “I used to participate in public speaking competitions from a young age and I love the entertainment space.”

 


 

“Enjoy university, meet new people and grab every opportunity that aligns with your purpose, have fun and most importantly, ensure that your academics are always in order,” Olebogeng advises the first-year students of 2023.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept